PhoenixBio Co., Ltd. (6190.T)
JPY 335.0
(-1.76%)
JPY 335.0
(-1.76%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | -79.3 Million | 277.49 Million | 16.39 Million | -101.9 Million | -12 Million |
| Net Income | 59.78 Million | 510.64 Million | -393 Million | -223.87 Million | -415 Million |
| Depreciation & Amortization | 25.22 Million | 23.7 Million | 86.23 Million | 55.44 Million | 84 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 29.02 Million | 18.84 Million | 15.77 Million | 12.45 Million | - |
| Change in working capital | -119.84 Million | -263.45 Million | 53.2 Million | 69.76 Million | -5 Million |
| Other non-cash items | -15.28 Million | -7.23 Million | -8.54 Million | -36.33 Million | 324 Million |
| Investing Cash Flow | 115.35 Million | -156.34 Million | -6.97 Million | -184.77 Million | -15 Million |
| Investments in PPE | -38.77 Million | -12.36 Million | -6.77 Million | -182.31 Million | -30 Million |
| Acquisitions | - | - | - | - | 14.59 Million |
| Investment purchases | -9.26 Million | -136.11 Million | - | - | - |
| Sales/Maturities of investments | 153.4 Million | - | - | - | - |
| Other Investing Activities | 9.99 Million | -7.85 Million | -204 Thousand | -2.45 Million | 1 Million |
| Financing Cash Flow | -244.87 Million | 86.63 Million | -34.65 Million | -160.19 Million | 1.14 Billion |
| Debt repayment | -480 Million | - | -2.48 Million | -220 Million | -974 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | -40 Thousand |
| Common Stock Issuance | 37.79 Million | 142.93 Million | - | 84.56 Million | - |
| Other Financing Activities | -725 Million | -1000.00 | -2.01 Million | -3.45 Million | 172 Million |
| Accounts receivables | 69 Million | -60 Million | -48 Million | 54 Million | 30 Million |
| Accounts payables | -27.3 Million | 2.34 Million | -4.57 Million | 8.48 Million | 1.4 Million |
| Inventory | -83.46 Million | -105.87 Million | -19.01 Million | -56.48 Million | -49 Million |
| Other working capital | -54 Million | -107 Million | 107 Million | 72 Million | 14 Million |
| Cash at beginning of period | 1.55 Billion | 1.32 Billion | 1.32 Billion | 1.77 Billion | 656.68 Million |
| Cash at end of period | 1.38 Billion | 1.55 Billion | 1.32 Billion | 1.32 Billion | 1.12 Billion |
| Capital Expenditure | -38.77 Million | -12.36 Million | -6.77 Million | -182.31 Million | -30 Million |
| Effect of forex changes on cash | 38.39 Million | 22.03 Million | 22.93 Million | -737 Thousand | 1 Million |
| Net cash flow / Change in cash | -170.43 Million | 229.81 Million | -2.3 Million | -447.61 Million | 463.31 Million |
| Free Cash Flow | -118.08 Million | 265.12 Million | 9.62 Million | -284.22 Million | -42 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 23 Million | 12 Million | 59.78 Million | -13 Million | -15 Million | 42 Million |
| Depreciation & Amortization | - | - | 25.22 Million | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | 29.02 Million | - | - | - |
| Change in working capital | - | - | -119.84 Million | - | - | - |
| Other non-cash items | -23 Million | -12 Million | -15.28 Million | 13 Million | 15 Million | -42 Million |
| Investing Cash Flow | - | - | 115.35 Million | - | - | - |
| Investments in PPE | - | - | -38.77 Million | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | -9.26 Million | - | - | - |
| Sales/Maturities of investments | - | - | 153.4 Million | - | - | - |
| Other Investing Activities | - | - | 9.99 Million | - | - | - |
| Financing Cash Flow | - | - | -244.87 Million | - | - | - |
| Debt repayment | - | - | -480 Million | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 37.79 Million | - | - | - |
| Other Financing Activities | - | - | -725 Million | - | - | - |
| Accounts receivables | - | - | 69 Million | - | - | - |
| Accounts payables | - | - | -27.3 Million | - | - | - |
| Inventory | - | - | -83.46 Million | - | - | - |
| Other working capital | - | - | -54 Million | - | - | - |
| Cash at beginning of period | - | - | 1.55 Billion | - | - | - |
| Cash at end of period | - | - | 1.38 Billion | - | - | - |
| Capital Expenditure | - | - | -38.77 Million | - | - | - |
| Effect of forex changes on cash | - | - | 38.39 Million | - | - | - |
| Net cash flow / Change in cash | - | - | -170.43 Million | - | - | - |
| Free Cash Flow | - | - | -118.08 Million | - | - | - |
YEWTF
001213
NTOIY
EHGRF
PHN
600567